Click Above for More Information on our Fall Forum!

Become intimately involved with AAMCN! We need your help, brainstorming and providing direction! We are looking for proactive members who would like to become more involved in making AAMCN the absolute best it can be. We value and desire your ideas and support!

Areas of Participation:

• Membership Development Council - We are always seeking out new members, and we would love your input on ideas for recruitment and retention
• Education Advancement Council - Health care is an ever-changing industry and we work hard to make sure our members are always educated on current trends and methods
• Leadership Institute - The Leadership Institute is designed to provide mentoring and education to members to become leaders in their organization and communities
• Research Institute - The goal of the Research Institute is to prove the value of care management and other patient advocacy through the use of tools & resources in marketplace  demonstration projects 

Interested in getting involved? Please contact Jennifer Turner at jturner@aamcn.org or by phone at 804.747.9698

---

Congratulations to the 2012 Managed Care Nurse Leader of the Year:



Jacquelyn Smith, RN, BSN, MA, CMCN
VP, Healthcare Programs
Amerigroup Community Care

                                                                        













    

 

 

 

 

 

 

 

 

 

 

 

 

President's Goal for 2012

"My goal is to encourage active involvement from all of our organizations both nurses and medical directors . I challenge all members to not only be personally active in the Association but to also be active organizationally."

 - Jacquelyn Smith, President, AAMCN

Corporate Partner of the Month!



Verinata Health, Inc. is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities through our proprietary technologies. We aim to reduce the anxiety associated with today’s multi-step process, the unacceptable false positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, and the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result.

Press Release: Real World Study Results Demonstrate Verinata Non-Invasive Prenatal Technology Detects Fetal Aneuploidies Across Entire Genome

---

CLICK HERE FOR THE CURRENT NURSES' NOTES ISSUE

AAMCN is going DIGITAL!

In an effort to 'Go-Green', AAMCN will now be going completely digital with ALL member benefits and communications, which will include email invoicing.

Please contact AAMCN with any questions, concerns, or to update your email address.